Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.

Bibliographic Details
Title: Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.
Authors: Schouten, Philip C., Schmidt, Sandra, Becker, Kerstin, Thiele, Holger, Nürnberg, Peter, Richters, Lisa, Ernst, Corinna, Treilleux, Isabelle, Medioni, Jacques, Heitz, Florian, Pisano, Carmela, Garcia, Yolanda, Petru, Edgar, Hietanen, Sakari, Colombo, Nicoletta, Vergote, Ignace, Nagao, Shoji, Linn, Sabine C., Pujade-Lauraine, Eric, Ray-Coquard, Isabelle
Source: JAMA Network Open; 4/9/2024, Vol. 7 Issue 4, pe245552-e245552, 1p
Database: Complementary Index
More Details
ISSN:25743805
DOI:10.1001/jamanetworkopen.2024.5552
Published in:JAMA Network Open
Language:English